Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth (tablets) |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.149.406 |
Chemical and physical data | |
Formula | C24H25FN6O |
Molar mass | 432.503 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
NY (what is this?) (verify) |
Mizolastine (Mizollen) is a once-daily, non-sedating antihistamine. It blocks H1 receptors and is commonly fast-acting. It does not prevent the actual release of histamine from mast cells, it only prevents histamine from binding to receptors. Side effects can include dry mouth and throat.
Antihistamines (R06) | |
---|---|
Benzimidazoles (*) | |
Diarylmethanes |
|
Ethylenediamines | |
Tricyclics |
|
Others |
|
For topical use |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |